CBIO
Crescent Biopharma, Inc.
14.30$
+0.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | |
| – | – | – | – | – | – | 9.4% | – | 1,376.2% | 1,533.0% | – | 0.8% | |
| 100.0% | 100.0% | 100.0% | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | |
| 130.2% | 124.8% | 125,847.7% | – | – | – | 442.1% | 4,094.9% | 37,854.5% | 200,716.6% | – | 1,273.4% | |
| 43.9% | 38.9% | 46,757.6% | – | – | – | 164.7% | 1,475.8% | 25,449.3% | 192,130.0% | – | 234.1% | |
| 174.1% | 163.7% | 172,605.3% | – | – | – | 606.8% | 5,570.7% | 63,304.4% | 392,852.9% | – | 1,507.5% | |
| -74.1% | -63.7% | -172,505.3% | – | – | – | -506.8% | -5,470.7% | -63,204.4% | -392,752.9% | – | -1,407.5% | |
| – | – | – | – | – | – | – | – | – | – | – | 20.1% | |
| -74.0% | -63.6% | -171,945.1% | – | – | – | -502.1% | -5,469.0% | -62,251.1% | -368,987.8% | – | -1,401.2% | |
| – | – | – | – | – | – | – | – | – | – | – | 18.4% | |
| -74.0% | -63.6% | -171,945.1% | – | – | – | -502.1% | -5,469.0% | -62,251.7% | -368,994.2% | – | -1,419.6% | |
| -73.1% | -62.7% | -171,475.4% | – | – | – | -504.2% | -5,447.9% | -62,927.6% | -391,213.6% | – | -1,380.2% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.